Yahoo
OTC Markets OTCPK - Delayed Quote USD

Virpax Pharmaceuticals, Inc. (VRPX)

0.0008 0.0000 (0.00%)
At close: October 28 at 4:00:00 PM EDT
View in AlphaSpace Currency in USD All numbers in thousands
Financial statements are getting an update on November 9
Preview it now to see what’s changing.
Learn more
Breakdown
TTM
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Total Revenue
0
0
0
0
0
Operating Expense
12,079.9350
12,079.9350
16,939.7890
21,845.1330
12,025.5000
Operating Income
-12,079.9350
-12,079.9350
-16,939.7890
-21,845.1330
-12,025.5000
Net Non Operating Interest Income Expense
-103.7500
-103.7500
--
0
-92.8220
Other Income Expense
116.4600
116.4600
1,750.2810
194.4130
62.2590
Pretax Income
-12,067.2250
-12,067.2250
-15,189.5080
-21,650.7200
-12,056.0630
Tax Provision
--
--
0
0
0
Net Income Common Stockholders
-12,067.2250
-12,067.2250
-15,189.5080
-21,650.7200
-12,056.0630
Diluted NI Available to Com Stockholders
-12,067.2250
-12,067.2250
-15,189.5080
-21,650.7200
-12,056.0630
Basic EPS
-71.00
--
-324.25
-462.50
-452.50
Diluted EPS
-71.00
--
-324.25
-462.50
-452.50
Basic Average Shares
170.1760
--
46.8490
46.8480
26.7090
Diluted Average Shares
170.1760
--
46.8490
46.8480
26.7090
Total Operating Income as Reported
-12,079.9350
-12,079.9350
-15,689.7890
-21,845.1330
-12,025.5000
Total Expenses
12,079.9350
12,079.9350
16,939.7890
21,845.1330
12,025.5000
Net Income from Continuing & Discontinued Operation
-12,067.2250
-12,067.2250
-15,189.5080
-21,650.7200
-12,056.0630
Normalized Income
-12,067.2250
-12,067.2250
-16,439.5080
-21,650.7200
-12,056.0630
Interest Expense
103.7500
103.7500
--
0
92.8220
Net Interest Income
-103.7500
-103.7500
--
0
-92.8220
EBIT
-11,963.4750
-11,963.4750
-16,939.7890
-21,845.1330
-11,963.2410
EBITDA
-11,963.4750
-11,963.4750
-16,939.7890
-21,845.1330
-11,963.2410
Net Income from Continuing Operation Net Minority Interest
-12,067.2250
-12,067.2250
-15,189.5080
-21,650.7200
-12,056.0630
Total Unusual Items Excluding Goodwill
--
--
1,250
--
--
Total Unusual Items
--
--
1,250
--
--
Normalized EBITDA
-11,963.4750
-11,963.4750
-18,189.7890
-21,845.1330
-11,963.2410
Tax Rate for Calcs
0
0
0
0
0
Tax Effect of Unusual Items
0
0
0
0
0
12/31/2021 - 2/17/2021

Upgrade to begin using 40 years of financial statements and get so much more.

Perform in-depth fundamental analysis with decades of income statements, balance sheets, and cash flows — all exportable.

Upgrade

Related Tickers

Mobilize your Website
View Site in Mobile | Classic
Share by: